Clinical Trial Update: Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

View source ↗

Summary

This update describes a completed clinical trial investigating whether specific blood protein biomarkers can predict treatment benefit in patients with recurren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Head and Neck Cancer | Status: COMPLETED